Jongen et al., 2009 [14] conclude that while patients with estrogen receptor-alpha positive tumours have better overall survival, the absence of progesterone receptor-A is also an independent prognostic factor for disease-free survival and disease relapse. The gene discussed is ESR1; the disease is neoplasm.